Skip to content

The Effectiveness of High-Intensity Laser Therapy (HILT) on de Quervain’s Tenosynovitis

The Effectiveness of High-Intensity Laser Therapy (HILT) on de Quervain’s Tenosynovitis: A Randomized, Double-Blinded (Patient and Assessor), Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190507004
Enrollment
34
Registered
2019-05-07
Start date
2019-05-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DeQuervain&#39

Interventions

High intensity laser therapy combine thumb spica splint,Sham High intensity laser therapy combine thumb spica splint
HILT + Splint,Sham HILT + Splint

Sponsors

Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Lead Sponsor
Ratchadapiseksompotch Fund&#44
Collaborator
Faculty of Medicine&#44
Collaborator
Chulalongkorn University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of de Quervain’s tenosynovitis Unilateral affected side Moderate to severe pain Age > 18 years old Informed consent

Exclusion criteria

Exclusion criteria: Previous treatment in these timeframes -Anti-inflammatory medication in 4 weeks -Physical modalities in 4 weeks -Corticosteroid injection in 6 months a History of other wrist/distal forearm disorders Skin disease at wrist History of surgery or trauma or deformities of the affected limb Neurological disease (e.g. C-radiculopathy, peripheral nerve entrapment) Systemic infection or rheumatologic disease Contraindication of HILT (e.g., Pregnancy/Tumor, /Epilepsy etc.) b

Design outcomes

Primary

MeasureTime frame
Pain before and after treatment Visual analogue scale

Secondary

MeasureTime frame
Hand power before and after treatment Grip strength

Countries

Thailand

Contacts

Public ContactTanach Chongkriengkrai

Physical and Rehabilitation Medicine, Faculty of Medicine, Chulalongkorn University

nachtanach39@gmail.com0840822124

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026